or were markedly improved (39 cases). This assessment also takes into account the presence of other pathology. In those patients given cefuroxime prophylactically, no cases of bacterial infection arose.
Bacteriology
shows the results of bacteriological examinations on 67 patients, carried out at the commencement and at the end of the therapeutic treatment with cefuroxime. These examinations were made on bronchial secretion, on urine and on other organic liquids. In the remaining 13 cases, the bacteriological analysis could not identify the causative agent. In 22 cases the infection was caused by more than one organism. At the end of the therapy, out of 76 bacteriological strains isolated, only 4 were persistent (I Streptococcus, I Klebsiella, I Proteus, and I Pseudomonas). Table 2 shows the diagnostic parameters anlysed by type of infection. They were constantly checked during the course of the disease. For simplicity, only the initial and final data are reported. Initial data express the number of patients bearing the symptoms of the disease, whereas final data are reported in percentage terms. We believe that by observing the trend of these parameters we can obtain a clearer idea about those cases previously described as 'having made progress'. Within the group we have included also those patients in whom the absence of pathogenic microorganisms was obtained but in which other symptoms of disease persisted.
Diagnostic Parameters

Tolerance
Tolerance to cefuroxime was studied in all 100 subjects with particular regard to the haemopoietic (hematocrit, haemoglobin, erythrocytes, leucocytes and thrombocytes), hepatic (serum bilirubin, Preliminary Clinical Experience with Cefuroxime: Report on One Hundred Cases by Professor G De Sandre (University of Verona, Italy) This paper reports the results obtained with the initial 100 patients treated with sodium cefuroxime in 5 centres, 3 in Verona, I in Cremona and I in Novara.
Patients and Methods
The therapeutic activity of this antibiotic was tested on 80 patients. A further 20 patients received treatment only as a prophylactic measure in connection with important surgical operations. The characteristics of the 2 groups are given separately.
The group of patients treated therapeutically consisted of 67 males and 13 females (average age 55.2 years) with infections of their respiratory system (60 cases), urinary tract (13 cases), and septicamia (7 cases). Cefuroxime was given in doses of 500, 750 or 1000 mg and, depending on the seriousness of the pathological picture, it was administered i.m. (56 cases) or i.v. (24 cases). The total dosage was 11-21 g i.m. (average 15.7 g) and 19-58 g i.v. (average 27 g).
The 20 patients having cefuroxime for prophylactic surgical cover (19 males and 1 female, average age 45 years) were divided on the basis of the type of surgery, i.e. cardiac, pulmonary, abdominal and vascular. Here the dosage and the system of administration was based on the complexity of the clinical picture.
Results and Discussion
In those patients treated for infection, the results obtained have been very satisfactory. Of 80 patients, 91.3 % were completely cured (34 cases), Table 1 Bacteriology (67 patients Table 3 shows the average values determined before and at the end of the therapeutic period and the significance of any differences. None of these parameters were significantly changed during the treatment. A reduction of leucocytes indicates an attenuation and resolution of the infective process. The improvement of a few indices of liver (serum bilirubin) and renal (creatinxmia) function are evidence of a probable improvement in the general debilitated state caused by the infectious process.
During the treatments no side effects ascribable to cefuroxime have been noticed. The occurrence of pain at the site of injection with i.m. injection was quite negligible even in the case of prolonged therapy. fntravenous injections in no cases caused phlebitis, thrombophlebitis or skin rashes.
Summary
Of a group of 80 patients suffering from infections of the respiratory system, urinary tract, or septicemia, 73 cases were either cured or markedly improved after treatment with cefuroxime. Twenty patients given the product as a prophylactic measure in connection with serious operations remained free of infection.
Of the 76 bacteriological strains isolated from the 80 infected patients, only 4 persisted after treatment.
No side-effects ascribable to cefuroxime were noted. 
